International Journal of Infectious Diseases

Article	Citations
Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts	563
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients	490
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis	429
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19	407
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa	299
Role of favipiravir in the treatment of COVID-19	290
Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis	283
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates	279
Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples	276
Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis	256
COVID-19 outbreak in Malaysia: Actions taken by the Malaysian government	246
Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis	243
Factors affecting perceived effectiveness of COVID-19 prevention measures among Filipinos during Enhanced Community Quarantine in Luzon, Philippines: Integrating Protection Motivation Theory and exten	238
COVID-19 and healthcare workers: A systematic review and meta-analysis	232
Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020	229
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome	222
Air pollution and temperature are associated with increased COVID-19 incidence: A time series study	212
Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients	206
COVID-19: Poor outcomes in patients with zinc deficiency	204
Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers	201
Nutritional status of patients with COVID-19	193
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial	192
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa	184
The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB	179
Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study	178

An analysis of COVID-19 vaccine sentiments and opinions on Twitter	174
Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible	172
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review	165
Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?	163
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness	163
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings	159
Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website	151
Side effects and perceptions following Sinopharm COVID-19 vaccination	151
Mask use, risk-mitigation behaviours and pandemic fatigue during the COVID-19 pandemic in five cities in Australia, the UK and USA: A cross-sectional survey	142
Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?	142
Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss	139
Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention	137
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in gl	133
Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak	127
An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination	123
Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19	114
Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis	113
Coronavirus outbreak in Nigeria: Burden and socio-medical response during the first 100 days	105
Possible aerosol transmission of COVID-19 associated with an outbreak in an apartment in Seoul, South Korea, 2020	105
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14	104
Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis	102
Africa’s low COVID-19 mortality rate: A paradox?	100
Therapeutic plasma exchange in adults with severe COVID-19 infection	99
Mast cell activation symptoms are prevalent in Long-COVID	96
Spatiotemporal pattern of COVID-19 and government response in South Korea (as of May 31, 2020)	94
Lack of antiviral activity of darunavir against SARS-CoV-2	94
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021	93
Main differences between the first and second waves of COVID-19 in Madrid, Spain	93
Spatial modeling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between February 19 and June 14, 2020)	93
Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity	93
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients	92
Asymptomatic hypoxia in COVID-19 is associated with poor outcome	92
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings	89
SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic	89
Mental health crisis under COVID-19 pandemic in Hong Kong, China	87
Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs	86
Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia	83
Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness	82
Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients	81
Estimating the undetected infections in the Covid-19 outbreak by harnessing capture–recapture methods	81
COVID-19 infection among healthcare workers in a national healthcare system: The Qatar experience	81
Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry	80
The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review	79
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate	77
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany	77
Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development	76
Marburg virus disease: A summary for clinicians	76
The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong–January to May 2020	76
Cluster infections play important roles in the rapid evolution of COVID-19 transmission: A systematic review	75
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review	75

Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination	75
Characteristics of healthcare workers infected with COVID-19: A cross-sectional observational study	74
SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standards for discharge	73
The incubation period of COVID-19: A meta-analysis	72
Temporal and spatial analysis of COVID-19 transmission in China and its influencing factors	72
Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples	72
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab	72
Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic	71
Antibody-dependent enhancement of coronavirus	71
Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity	70
Analysis of the predictive factors for a critical illness of COVID-19 during treatment － relationship between serum zinc level and critical illness of COVID-19 −	70
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count	70
Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report	69
Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis	67
Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs	67
Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial	66
Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples	65
Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases	65
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2	65
Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19	65
Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control	65
Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by COVID-19: An interventional study	64
The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2	63
Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia	63
Ending the epidemic of HIV/AIDS by 2030: Will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries?	62
Critical illness myopathy after COVID-19	62
Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study	62
Addressing Africa’s pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa	61
SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens	61
A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient	61
Epidemiological and clinical characteristics of coronavirus disease 2019 in Daegu, South Korea	60
Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients	60
Clinical features and short-term outcomes of elderly patients with COVID-19	59
Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar	59
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection	58
Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic	57
Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020	57
New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France	57
Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection	57
Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?	56
Predictors and outcomes of healthcare-associated infections in COVID-19 patients	56
Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients	56
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study	55
Contact tracing with digital assistance in Taiwan’s COVID-19 outbreak response	55
Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020–2021 season of COVID-19	55
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge	55
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh	54
Follow-up study on COVID-19 survivors one year after discharge from hospital	54
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage	54
Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression	54
Genomic sequencing effort for SARS-CoV-2 by country during the pandemic	54
Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report	53
Spatiotemporal dynamics of the COVID-19 pandemic in the State of Kuwait	53
COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia	53
Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals	52
Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia	52
Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection	52
Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3.	52
Sudden sensorineural hearing loss after COVID-19 vaccination	51
A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19	51
The role of children in household transmission of COVID-19: a systematic review and meta-analysis	51
The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients	51
Herd immunity and vaccination of children for COVID-19	50
COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies	50
Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19	50
Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR	50
Saliva is a reliable and accessible source for the detection of SARS-CoV-2	50
COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan	50
Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019–2020 in Parma, Northern Italy	50
The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States	49
Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge	49
The effect of ultraviolet C radiation against different N95 respirators inoculated with SARS-CoV-2	49
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19	49
Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants	49
Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South Korea	49
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study	48
A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease	48
Herpes zoster after COVID vaccination	48
COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report	48
Was school closure effective in mitigating coronavirus disease 2019 (COVID-19)? Time series analysis using Bayesian inference	48

Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients	48
Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis	47
Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database	47
Covid-19 and blood groups: ABO antibody levels may also matter	47
Drug resistant TB – latest developments in epidemiology, diagnostics and management	47
SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial	47
Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19	47
Longitudinal profiling of the vaccination coverage in Brazil reveals a recent change in the patterns hallmarked by differential reduction across regions	46
Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity	46
Bacterial co-infection at hospital admission in patients with COVID-19	46
SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021	46
Arginine depletion as a therapeutic approach for patients with COVID-19	45
What works and what does not work in response to COVID-19 prevention and control in Africa	45
Air and surface contamination by SARS-CoV-2 virus in a tertiary hospital in Wuhan, China	45
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study	45
Metagenomic next-generation sequencing technology for detection of pathogens in blood of critically ill patients	45
Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia	45
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients	45
Estimating the instant case fatality rate of COVID-19 in China	44
The impact of COVID-19 on health care–associated infections in intensive care units in low- and middle-income countries: International Nosocomial Infection Control Consortium (INICC) findings	44
Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis	44
Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria	44
SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance	43
Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa	43
COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications	43
Relationship of the cycle threshold values of SARS-CoV-2 polymerase chain reaction and total severity score of computerized tomography in patients with COVID 19	43
A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer	43
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients	43
COVID-19 in people living with HIV: A multicenter case-series study	43
Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection	42
Impact of the COVID-19 pandemic on tuberculosis management in Spain	42
Social consequences of COVID-19 in a low resource setting in Sierra Leone, West Africa	42
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay	41
Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak	41
First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution	41
Facemask use in community settings to prevent respiratory infection transmission: A rapid review and meta-analysis	41
COVID-19 vaccine acceptance in South Asia: a multi-country study	41
The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects	41
COVID toes: where do we stand with the current evidence?	41
Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period	41
Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening	41
Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia	41
Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals	41
Transmission dynamics of the COVID-19 epidemic in India and modeling optimal lockdown exit strategies	40
Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study	40
COVID-19 epidemic in Brazil: Where are we at?	40
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)	40
Clinical applications of detecting IgG, IgM or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review	40
The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): A systematic review and meta-analysis	40
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya	40
Pandemic preparedness and response to COVID-19 in South Asian countries	39
Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as of November 20, 2020	39
Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir	39
SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19	39
The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients	39
Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome	38
Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study	38
Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach	38
HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes	38
Safe hospital preparedness in the era of COVID-19: The Swiss cheese model	38
Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting	38
Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant	38
Neurosensory dysfunction: A diagnostic marker of early COVID-19	38
Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters	38
Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation	37
Spread of COVID-19 and policy responses in Vietnam: An overview	37
Characteristics of long-COVID among older adults: a cross-sectional study	37
Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya	37
Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates	37
Risk of COVID-19 morbidity and mortality among healthcare workers working in a Large Tertiary Care Hospital	37
Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young migrant workers with reduced risk of severe disease	37
Zoonotic Tuberculosis – The Changing Landscape	37
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report	37
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic	37
Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis	37
Transmission onset distribution of COVID-19	37
Association of schistosomiasis and HIV infections: A systematic review and meta-analysis	37
Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study	37
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States	36
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa	36
A simple approach to optimum pool size for pooled SARS-CoV-2 testing	36
Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa	36
Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification	36
A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic	36
Trends in the disease burden of HBV and HCV infection in China from 1990-2019	36
Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial	36
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study	36
COVID-19 hospital outbreaks: Protecting healthcare workers to protect frail patients. An Italian observational cohort study	36
Appropriate use of tocilizumab in COVID-19 infection	35
Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use	35
A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19	35
What factors drive the satisfaction of citizens with governments’ responses to COVID-19?	35
Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China	35
Antibiotic use in Kenyan public hospitals: Prevalence, appropriateness and link to guideline availability	35
Prevalence of Parental refusal rate and its associated factors in routine immunization by using WHO Vaccine Hesitancy tool: A Cross sectional study at district Bannu, KP, Pakistan	35